Osprey Pharma names new CEO
September 27, 2007 | David P. Hamilton
See our story about this San Francisco company in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Venture firm Draper Fisher Jurvetson goes to Russia
Previous Story: Corium acquires StrataGent, raises $25.1M for “transdermal” drugs
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.












